Hester Biosciences has achieved 94% sales target in India for the 9 months ended December 31, 2018 (April-December 2018). The profitability improved during the period. This improvement is attributed to a better product mix, better inventory management and a reduction in the cost of production.
Hester Biosciences is engaged in the manufacturing of poultry vaccines.